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PURPOSE
The purpose of this work was to study and select

.

from thirty different drugs those with the ability to partially or completely suppress the infectivity of Newcastle
disease virus and vesicular stomatitis virus in tissue cultures.

Drug(s) showing significant activity in tissue cul-

tures should be tried out in fertilized eggs or animals. Finally, the drug(s) with therapeutic activity in vitro and in
vivo should be further studied using biological, biochemical
and histochemical techniques, in order if possible, to elucidate the mechanism(s} of it~(their) inhibitory action.
The general purpose of this work was to contribute
to the field of Chemotherapy of viral diseases, which due to
very intricate virus-host cell relationships, has not been
achieved on a practical and clinical level.
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CHAPTER I
INTRODUCTION
In 1909 Ehrlich proposed the word chemotherapy to
denote the concept of therapy of bacterial diseases by means
of drugs selectively toxic for the parasites.
On this basis chemotherapy is defined as the treatment of infectious diseases in vivo by chemical

agen~s

which

are specifically toxic for the etiological agents without ser
ious toxic or damaging effects for the host.
The discovery by Domagk (1935) that prontosil, an
azo dye, significantly inhibited streptococcal infections in
mice with no toxic effect for mice, and subsequent findings
on the mechanism of its action by Woods (1940), prompted
Fildes (1940) to propose a rational approach to research in
chemotherapy of infectious diseases.

This approach was log-

ical, and synthetic compounds such as sulfones, aminohydroxybenzoic acid and the derivatives of pyridine carboxylic acid
were found which are used successfully against infections
caused by acid fast bacilli (Burrows, 1955).
The discovery of penicillin and streptomycin and
later of broad spectrum antibiotics such as tetracyclines and
chloramphenicol greatly contributed to the array of therapeutic agents available for treatment of bacterial diseases
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and also diseases caused by rickettsiae and chlamydozoa.
The studies of the mechanisms of the action of
these agents pointed to selective inhibition of various metabolic activities which had a lethal or inhibiting effect on
the pathogen.

The inability of gram positive bacteria to

synthesize their cell wall in the presence of penicillin'
(Lederberg, 1957), or the inhibition by streptomycin of the
Krebs cycle (Oginskyand Umbreit, 1954), and the interference
with transamination reactions of Mycobacterjum tuberculosis
by isonicotinic acid hydrazide are only a few examples of
inhibitory mechanisms.
The results of these studies demonstrate that chemo
therapy is possible if the parasite exhibits metabolic activity which may be inhibited by a drug.
Chemotherapy today is relatively successful in combating many diseases of protozoan, bacterial, rickettsial and
chlamydozoan etiology, whether the parasite is found intracellularly or extracellularly.

The only group of obligate

intracellular parasites against which chemotherapy has been
ineffective is the group of "true" viruses.

It becomes clear

that the intracellular mode of life of diversified organisms
and entities, when examined from the viewpoint of chemotherapy, is graded, and therefore should depend on different factors.

The reproduction of viruses and the metabolism of the

host cells is such an intimately shared mechanism that selective inhibition of virus is difficult.

CHAPTER II
HISTORY
The word virus comes from the Latin noun meaning
venom or similar toxic fluid.

It was used from ancient times

until very recently, denoting all sorts of noxious and poisonous agents,. (Fraenkel-Conrat, 1962).
"virus" is an intractable one.

Even today the word

It (virus) refers to a charac-

teristic complex of recognizable qualities associated with a
natural or experimental disease rather than to the individual
unit or microorganism which one tends to speak of as a virus
particle (Burnet, 1960).
Viruses probably would never have been discovered if
they did not .nave the property of causing disease.

The idea

of submicroscopic nonbacterial pathogens was very slow in
finding its experimental basis (Luria, 1953).
slow.

Progress was

A century before Iwanovski reported the transmission of

tobacco mosaic disease by means of sap filtered through bacteriological

filters~

Jenner was successful in vaccinating the

children of England with "Variolae Vaccinae."

Transmission of

rabies from a rabid to a normal dog by means of filtered saliva was reported by Zinke in 1804, some

seventy~five

fore Pasteur's preparation of antirabies vaccine.
them knew the true nature of these agents.

years beNone of

Pasteur might have
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perceived the true biological character of the rabies virus,
but it remained for bacteriologist Beijerinck (1899), after
rediscovering the virus of tobacco mosaic disease, to recognize that he was dealing with a new type of biological agent,
and promptly called it, on the basis of its filterability
through bacteriological filters, "contagium vivum fluidum."
Following Beijerinck's work, a number of people discovered a variety of filterable infectious agents.

Borrel

(1904) reported the discovery of the agent of fowl plague;
Paschen (1906) rediscovered the elementary particles of vaccinia, which were studied and called by Buist (1887) micrococci of vaccinia; von Prowazek (1907) describes trachoma and
Landsteiner and Popper (1909) poliomyelitis virus.
In the three decades following the work of

Beijer~~

important progress in the study of the cellular pathology of
several viral diseases had been achieved.

(Negri, 1903;

Councilman, 1904; da Rocha Lima, 1912; Denton, 1925; Lillie,
1930), Despite this, virology as an integrated part within the
broader scope of microbiology did not exist.
With the discovery of bacterial viruses by Twort
-(1915) and d'Herelle (1917), and their subsequent study (Burnet and McKie, 1929; Ellis and Delbruck, 1939; Hershey, 1946),
it became clearer that for successful study of the properties
of animal viruses a simple host system should be used.
The inability to measure quantitatively viral
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infe ctiv ity in simp le syste ms on one hand and
the need for
such stud ies on the othe r, distu rbed earl y viro
logi sts, as onE
can conc lude from Ende rs (195 9):
It is not surp risin g that attem pts to prop agat
e
anim al viru ses and rick etts iae in isola ted syste
ms
of cell s follo wed the deve lopm ent by Harr ison
(190
of a ~imple meth od of tissu e cult ure, for it was 7)
earl y appa rent to most obse rver s that thes e agen
ts,
unli ke bact eria , fail to mult iply in life less
medi a.
Alth ough the meth od was appl ied in the past effe
ivel y to the inve stiga tion of seve ral fund amen ctprob lems rela ting to anim al viru ses, durin g a tal
long
perio d it did not appe ar to offe r adva ntag es for
thei r cult ivat ion and stud y prov ided by the susc
ible anim al, sinc e it was cons idere d that vira eptl increa se in cell syste ms coul d be dem onst rated reliab ly only by inoc ulati on of appr opri ate anim
als
with cons titue nts of the cult ure. Rece ntly,
however , tissu e cult ure has assum ed the statu s of
a
majo r tech nic in the viru s labo rato ry.
Ther e are actu ally thre e good reas ons for this
deve lopm ent:
a)
use of anti biot ics in the medi um supp ortin g the
grow th of cell s whic h are the host s for a vari
ety
of viru ses, made it poss ible to prep are tissu e
cult ures on a larg e scal e and perm itted dire ct
i50latio n of viru ses from cont amin ated mate rials ;
b)

use of Rous and Jone s (191 6)

tech nic of tryp sini za-

tion of tissu es in the prep arati on of cell ular
suspens ions ;
c)

obse rvat ion and reco gnit ion that many viru ses,
when pres ent in tissu e cult ures and mult iply ing
in the cell s are resp onsi ble for dege nera tive
chan ges, whic h are easi ly dete cted and know n unde
r
gene ral term s of cyto path ic effe cts (Hua ng, 1942
).
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With the adva ncem ent of mode rn tissu e cult ure
tech niqu es many conc epts abou t viru ses were reaff irme
d and some
had to be chan ged.

Ihe natu re of viru ses.

Some phys ical. chem ical and biol ogic al

j2To peTt ies.
Repo rts on infe ctio us agen ts pass ing filte rs reta
inin g even
the sma llest bact eria indi cate d to earl y work ers
thei r dimi nutive size s.
But it was actu ally Elfo rd (193 1) who publ ishe d
the firs t repo rts on the estim ation of the size
s of viru ses,
using grad ed collo dion mem brane s.

Late r, the use of the elec -

tron micr osco pe and the ultra cent rifu ge impr oved
thes e meas urem ents.
The appl icati on of the elec tron micr osco pe with
newe r tech niqu es have give n us more deta ils of
vira l morp holo gy (How atson and Whit more , 1962 ; Bren ner and Horn
e, 1959 ).
'.

The firs t work on the chem ical prop ertie s of viru
ses
was done by Vins on and Petr e (192 9, 1931 ) whic
h led to the
crys talli zati on of toba cco mosa ic viru s by Stan
ley (193 5) and,
amon g othe rs, poli omy eliti s viru s by Scha ffer
and Schw erdt
(195 5). Chem ical anal yses of "pur ified " viru s
prep arati ons
repo rt find ings of nucl eic acid s, prot ein, and
in some instan ces, lipid s and poly sach arid es (Tay lor et al.,
1942 ;Sma del
and Hoag land , 1942 ; Ada and Perr y, 1954 ).

All viru ses cont ain

eith er RNA or DNA and prot ein and in some case
s (Myx oviru ses)
exhi bit enzy mati c prop ertie s. Lipi d and poly sach
aride
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materials mayor may not be considered integral parts of viru
Some people believe that the lipids found in some viruses are
acquired by the virus as it emerges through the cytoplasmic
membrane.

Treating viruses to remove lipids renders them non-

infective (Theiler, 1957; Franklin, 1962).

Viruses when in-

troduced into their hosts, stimulate the immune mechanisms to
produce antibodies.

This is due to the antigenic nature of

their proteins and nucleoproteins.

Since these antibodies are

in many instances protective, inactivated or attenuated viral
preparations are used as vaccines (Schaffer and Zillig, 1954;
Sabin, 1957; Salk, 1955).
Viruses exhibit the properties of genetically individual entities.

They are subject to genetic mutations.

For

example, the recovery of different, but serologically stable
strains of Influenza A virus since the pandemic of 1918 (Francis, et al., 1953; Hennesy, 1955).

Other studies confirm the

ability of viruses to mutate and recombine, giving stable, new
types, which differ from the parent types, either in host
range, virulence or sensitivity to various agents (Berry and
Dedrick, 1936; Luria, 1956).
Rous (1911) showed that viruses are responsible for
some tumor formation in chickens.

In recent years, it was

shown by Gross (1956) that mouse leukemia could be transferred
from one animal to another by means of a filtrate of leukemic
tissue.

Shope (1933) isolated a virus (Shope papilloma) from
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naturally occurring papillomas of wild rabbits.
loma is a nonmalignant growth.

This papil-

If filtrates of such tumors

are inoculated into the skin of either wild or domestic rabbits, tumors are induced in the animals.

Virus could be re-

isolated from wild rabbits but not from the tumors in domestic
animals.

Such papillomas are usually benign growths, but af-

ter long periods of time (Kidd and Rous, 1940) they may become malignant.
During 1950 it was demonstrated that the nucleic
acids of viruses were the carriers of the biological information necessary for their replication.

Hershey and Chase (1952)

in what are considered classical experiments, demonstrated
this with bacterial viruses using radioisotope techniques.
Direct evidence for this phenomenon comes from work of Alexander et al ••

(19~8)

in which the infectivity of poliomyelitis

virus RNA was proven on HeLa cells.

Since in nature virus

nucleic acids are contained in a protective protein coat, a
successful contact between the viral protein coat and the surface of a susceptible cell is a prerequisite for penetration
of the cellular membrane by viral nucleic acid.

In all sys-

tems so far studied specific electrolyte requirements exist,
(Kozloff et al •• 1957) for the attachment and adsorption of a
~ral

particle to the surface of a cell.

The discovery of ag-

glutination of chicken erythrcytes by influenza viruses by
Hirst (1941) and the study of its mechanism by S. Gottschalk
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(1956) pointed to the phenomenon of adsorption of viral particles to the receptor groups on the surface of susceptible
cells, as the first

~tep

in subsequent events.

Various histochemical procedures {Coons, 1958. 1959;
Armstrong, 1956; Anderson, et al., 1959} confirmed the concept
of an eclipse period as a part of the latent period of viral
intracellular development.

This concept was proposed by Ellis

and Delbruck (1939), as a result of their "One step growth experiments," with bacterial viruses and later applied to animal
viruses by Dulbecco (1952) and Dulbecco and Vogt (1954).
During this period the first comprehensive definitions of "virus" were proposed.

Luria (1956) defined it as

follows: "Viruses are submicroscopic

entitie~,

capable of be-

lng introduced into specific living cells, and of reproducing
inside such cells only."

Due to quick development of new con-

cepts based on new findings and hypotheses, Luria (1958) defines the "virus" somewhat differently:
Viruses could be considered as genetically specific
cell constituents, containing coded DNA or RNA which
can, as one of their genetic functions, determine
their own incorporation into specific vehicles for
transmission to other cells.
Experim~Dtal chemotherapy of viral diseases

The first attempts at the chemotherapy of viral diseases appeared in the literature in late 1940.

There are a number of

good reviews on the progress to date in this area.

For
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example, Matthews and Smith (1955), Hurst and Hull (1956),
Horsfall and Tamm (1957) and Staehelin (1959).

A.

Amino acids and analogs
Thompson (1947) reported that dl-methoxinine, an

analog of methionine, inhibits the growth of vaccinia virus in
Maitland type (minced) tissue cultures of chicken embryos.
Rafelson, et al., (1950) found that beta-2-thienylalanine inhibited multiplication of Theiler's GO VIr virus in minced
mouse brains, with no apparent effect on the uptake by this
tissue of p32 into its lipid and protein bound fractions •. It
was also reported in the same paper, that lysine, and to a
somewhat lesser extent, tryptophan and histidine inhibited the
growth of GO VII virus, and that the inhibition by lysine was
reversed by methionine.
Ackermann (1951) showed that methoxinine inhibited
the growth of PR 8 strain of Influenza A virus in intact tissue cultures of chicken chorioallantoic· membrane (CAM).

The

inhibitory effect of methoxinine was reversed by L-methionine
but not O-methionine, cysteine, creatine, betaine or choline.
Methoxinine did not affect the oxygen uptake by CAM.

Acker-

mann and Maassab (1954) found that methoxinine inhibits the
growth of Influenza virus if it was added 2-3 hours after
viral adsorption on CAM.

On the other hand, alpha-amino-p-

methoxyphenylmethanesulfonic acid was inhibitory only at the
initial stage of infection causing delayed viral release from

~'-------------------------------------------------,
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the CAM cells.
Inhibition of the Lansing strain of poliomyelitis
virus by DL-ethionine in minced human embryonic brain was reported by Brown and Ackermann (1951).

In this case methionine

competitively inhibited the action of Dl-ethionine, which was
not virucidal in vitro, and which did not irreversibly affect
the tissue.

Basic amino acids such as lysine, arginine and

ornithine, at concentrations from 1-10 mg per ml of growth
medium, retarded the growth of Influenza A and B viruses as
well as Mumps virus in minced tissue cultures of chicken CAM,
according to Eaton et al.,
(1955)

(1951).

Ackermann and Maassab

showed that inhibitory properties of 5-fluorophenylala-

nine (FPA) on the Influenza virus when grown in CAlVi differ
from those of methoxinine.

Release of FPA inhibition results

in immediate continuation of viral production, whereas in the
case of methoxinine at least a two hour lag ensues before any
detectable increase in viral infectivity could be measured.
Kundin et al.,

(1959) reported that several amino

acids and their derivatives inhibit the growth of Influenza A
and B viruses in chicken embryo lung tissue cultures.

Partic-

ularly good inhibition was achieved with norleucine, betaphenylserine, allylglycine and ethylcysteine.
It has been shown that 5-fluorophenylalanine inhibit
the growth of foot and mouth virus (Brown et al., 1961). poliomyelitis virus (Levintow and Darnell, 1961), fowl plague
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(Zimm erman n and Scha ffer, 1960 ) in diff eren t host
syste ms and
unde r a vari ety of cond ition s.
B.

Puri nes and pyrim idine anal ogs

Puri ne and pyrim idine anal ogs can act in two ways
.
They eith er inhi bit metabo~ic step s lead ing to
the synt hesi s
of nucl eic acid s. or by virtu e of thei r inco rpor
ation into
viru s nucl eic acid s they can decr ease vira l infe
ctiv ity or
prod uce nonf unct iona l nucl eic acid s.
It was show n by Matt hews (195 3) that 8-az agua nine
is
the most activ e inhi bito r of toba cco mosa ic viru
s in a seri es
of puri ne and pyrim idine anal ogs. The acti vity
was prob ably
due to its inco rpor ation into RNA of viru s (Mat
thew s and Smit h
1955 ), beca use the only othe r activ e anal ogs. 8-az
aade nine and
4 (5)-A mino -1H- l, 2, 3-Tr iazo lo-5 (4)-c arbo xam ide
were also incorp orate d.

Haas and Stew art (195 6) repo rted the syne rgis tic
inhi bito ry effe ct of8- azag uani ne and ame thop terin
on lymp hocytic chor iome ning itis viru s in mice .
Thio urac il was repo rted to inhi bit toba cco mosa
ic
viru s in toba cco plan ts (Com mone r and Merc er, 1951
). The ef-

'.i

,

.

...

fect of thio urac il coul d be reve rsed by urac il
(Com mone r and
Merc er, 1952 ). This coul d be done only durin g
earl y stag es
of infe ctio n as repo rted by Jeen er {195 7}.
Knox et al •• (195 7) show ed that 2-th iour acil , 2-th
io
4-ph enyl -6-o xy-p yrim idine . 5-m ethy l-2-t hiou raci
l and 4,6diam ino- 5-ni tro-2 -thio -pyr imid ine com plete ly supp
ress the

......
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growth of poliomyelitis virus in cultures of monkey testicles
for a period up to 12 days.

In monkey kidney cultures, growth

waS delayed for 24 hours and even then it was significantly
lower than in controls.

Higher concentrations of the drugs

were needed to inhibit type 1 than types 2 or 3 virus.

This

inhibition was reversed by addition of normal pyrimidines.
Amos and Vollmayer (1955) reported the inhibitory effects of
thiouracil on Influenza A virus in CAM and deembryonated
chicken eggs.

Infectivity and hemagglutinating activity of

the virus was suppressed.

Uracil acted competitively; since

it could overcome the effect of thiouracil.

Minton et

al.,

(1953) showed that phenoxy thiouracil protected mice against
intranasal or intracerebral infections by vaccinia.

The

compound could be given intraperitoneally or with the diet,
but it was not effective if given 2 days after infection.
Flu·orouracil (Kaplan and Ben-Porat, 1961) inhibi ts the formation of infective pseudorabies virus in rabbit kidney cells.
This inhibition was overcome by thymidine.

The same drug pro-

longs the life of mice infected intracerebrally with lymphocytic choriomeningitis virus (Levy and Haas, 1958).
~t al.,

Rich

(1962) found that 5-f1uorodeoxyuridine (FUDR) does not

inhibit the synthesis of Rous sarcoma virus in chick embryo
fibroblasts.

FUDR, on the other hand, inhibits the multipli-

cation of DNA containing vaccinia virus (Salzman et al.,1963).
Tenfold to hundredfold higher concentrations of FUDR had no

~:

-
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effect on the rate of formation or final yield of RNA containing poliomyelitis virus, and Salzman suggests that FUDR could
be used as a means of distinguishing between RNA and DNA containing viruses.

c.

Benzimidazole and derivatives
Work

~n

benzimidazole compounds provides one of the

more interesting recent developments in animal virus chemotherapy.

This compound has some inhibitory effect on a number

of viruses'" (Matthews and Smith, 1955).

Extensive screening

of benzimidazole derivatives and studies of their action on a
number of viruses was started by Tamm in 1953 and continued
until this date.

Tamm (1956) showed that alkylated and halo-

genated benzimidazoles are much more inhibitory for influenza
virus than benzimidazole, a component of vitamin B12 •
In
another paper; Tamm (1956a) showed that beta-D-ribofuranosyl
derivatives of benzimidazole are active at lower concentration
and also that they were much more selective in their activity,
since the ratio between toxic and inhibitory concentrations
was two times higher in the case of 5, 6-dichloro-beta-DribofuranosyJ:.benzimidazole (DRB) and 6 times as high with 4,
5,6-trichloro-beta-D-ribofuranosyl-benzimidazole (TRE) when
compared with free benzimidazole.

This action was specific

for beta ribofuranoside, the natural form in which nucleotides
are .present in RNA.
Virus.

Influenza virus is an RNA containing

Vaccinia virus, a DNA containing virus, is not
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inhi bited by thes e benz imid azol e deri vati ves, whic
h is surprisi ng (ramm and Neme s, 1957 ).

But poli omy eliti s viru s was

inhi bited by an D-ar abin osyl deri vati ve, and ther
efor e the
inhi bitio n of RNA cont ainin g viru ses in this case
is not too
clea r. This work was done most ly in tissu e cult
ures and eggs ,
but ther e was also some acti vity in anim als. Rece
ntly Tamm
~ al.,

(196 1) and Egge rs and Tamm (196 1) show ed that
2(-a lpha
Hydr oxyb enzy l)-be nzim idazo le (HBB) is perh aps the
most sele ctive vira l inhi bito r amon g the vari ety of benz imid
azol e deriva tive s whic h have been so far stud ied.

Stru ctur ally HBB

is not an anal og of any know n meta boli te, but it
inhi bits revers ibly a late step in repl icat ion of many ente
rovi ruse s by
an unkn own mech anism . Kissm an et ale, (195 7) repo
rt on the
othe r hand that DRB was inac tive agai nst PR 8 stra
in of Influen za A viru s .. in mice .
D.· Misc ellan eous comp ound s
Capr ochl oren e (liu et al., 1957 )

redu ced infe ctiv -

ity and hem aggl utini n tite rs of PR 8 influ enza
viru s in deembr yona ted eggs . Twen ty hour s afte r infe ctio n
with viru s the
comp ound was activ e, altho ugh not as mark edly as
in earl ier
treat men t.

The comp ound prot ecte d mice almo st com plete ly
(19
out of 20) agai nst the viru s.
Hamr e et alp, (195 1) repo rted
the abil ity of thios emic arba zone s to inhi bit mul
tipli cati on
of vacc inia viru s in mice .

Mep acrin e,

an anti mal aria l drug ,

(Gre enha lgh et al.,1 956) prot ecte d mice agai nst
larg e dose s of
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°a numb er of arbo r viru ses when the drug was give
n oral ly soon
afte r infe ctio n. Xero sine , an anti biot ic obta ined
from an
Achr omob acter spec ies, show ed a numb er of inte rest
ing prop erties (Gro upe, et al., 1952 ).
If mice were infe cted intr anasa lly with 10,0 00 LD50 of influ enza A viru s,
subc utan eous
xero sine was effe ctiv e even 48 hour s afte r infe
ctio n of the
anim als. Oral ly, xero sine was not effe ctiv e, and
high ly
toxic when give n intra peri tone ally .

It seem s that tissu e re-

actio ns have an impo rtant role in treat men t with
xero sine ,
rath er than its abil ity to; supp ress vira l mul tipli
catio n
(Gro upe et al., 1954 ).
Chro wthe r and Meln ick (196 1) foun d that guan idine
. Hel
inhi bite d prod uctio n of poli omy eliti s viru s in
monk ey kidney tissu e cult ures .

Righ tsel et a 1., (196 1)

repo rted

the inhi bitio Q of vari ouse nter ovir uses by this
comp ound .
Trea tmen t of monk eys infe cted with poli omy eliti
s viru s was
unsu cces sful.
Mito myci n C,
caes pitQ sus,

an anti biot ic prod uct of

Strep tomy ces

acco rding to Reic h and Fran klin (196 1) does

not inhi bit the RNA cont ainin g Meng o viru s at
the dose s whic h
mark edly supp resse d DNA cont ainin g vacc inia viru
s.
Shat kin
t l al., (196 1)
stud ied the effe ct of mito myci n C on mammall ian cell s, and repo rted that it caus es diss
olut ion of the
nucl ear appa ratus in a mann er simi lar to ioni zing
radi atio n.
Repo rts by Ben- Pora t et al.,

(1961 ) on the form ation of in-

0'-
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complete pseudorabies virus in rabbit kidney cells in the
presence of mitomycin, and only very slight inhibition (Gomato
et al., 1962)
-tion
on DNA.

of Reovirus type 3 in L cells, confirms its ac-

Puromycin (Levintow et al., 1962) inhibits multiplication and maturation of poliomyelitis virus in HeLa cells
when the infected cells are treated early.

Removal of puro-

mycin by washing of the infected cells brings about resumption
of normal viral replication.

Baltimore and Franklin (1962)

and Franklin and Baltimore (1962) reported that puromycin inhibits the formation of Mengo virus RNA in L-fibroblast cells,
probably through the mechanism of blocking the formation of
new protein in the infected cells that might serve as virus
specific RNA polymerases.
A number of basic dyes were studied as possible vir
therapeutics (Matthews and Smith, 1955).
Ing were not too promising.

The findings result-

More recently the inhibitory ac-

tion of proflavine on fowl plague virus was reported by
Franklin (1958).
E.

Interferon
Isaacs and Lindemann (1957) rep6rted discovery of a

proteinaceous substance which they called interferon, and
which is the product of virus-infected cells. According to a
number of investigators, interferons from various sources have
a wide spectrum of antiviral action and exhibit no particular

....

,...;'
t

.
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spec ifici ty for the viru ses resp onsi ble for thei
r form ation .
The diff icul ty in usin g inte rfero n as a ther apeu
tic agen t is
the inab ility to prep are and puri fy it in the quan
titie s whic h
could be effe ctiv e in man and anim als.

CHAPTER III
MATERIAL AND METHODS
Viru ses used ·in this work were obta ined from
Dr. F. Dein hard t, St. Luke -Pre sbyt erian Hos pital
, Chic ago,
Illin ois, and Dr. D. Hamr e, Univ ersit y of Chic ago,
Chic ago,
Illin ois.
The Roak in stra in of New castl e dise ase viru s (NOV
)
was pass ed twic e in eggs , befo re stoc ks were made
.
Prio r to
that , viru s was pass ed 7 time s at Rutg ers Univ
ersit y, 17 time s
at the Univ ersit y of Wisc onsin and seve ral time
s at the Univ ersi ty of Chic ago. The LD50 tite r of this stra
in for chic ken
embr yo can reac h 10 9 and it is unifo rmly leth al
when inoc ulate d

intracer~brally.

Hem olysi n tite rs of 1:12 8 were ob-

serve d and hem aggl utini n (HA) tite rs of 1:12 80.
The India na stra in of vesi cula r stom atiti s viru
s
(VSV) was pass ed intra cere bral ly in mice seve ral
hund red time

s

as well as nume rous foot pad pass ages in mice ,
seve ral epithel ial pass ages in catt le and hors es and more
than 20 passage s in eggs .
In our labo rato ry it was pass ed 3 time s throu g'h
chick en eggs befo re prep arati ons of vira l stoc ks.
Fert ilize d, whit e legh orn chic ken eggs were obta
ined
once a week from a near by hatc hery , and incu bate
d at 37 0 C upon
arri val. Ten day- old embr yos serv ed as sour ce
of prim ary

20
embr yonic cell s, othe rwis e the eggs were used for
prep arati on
of vira l stoc ks and for embr yo surv ival expe rime
nts. Seve ral
eggs were perm itted to hatc h, and chic kens used
as a sour ce
of bloo d for hem aggl utina tion (HA) and hem aggl
utina tioninhi bitio n (HI) test s.
He La cell s were obta ined from Capp el Labo rato ries,
Inc. , and cont inuo usly cult ivat ed in mini mal esse
ntia l medi um
(MEM) of Eagl e (195 9).
Medi a and solu tion s
Phos phat e buff ered salin e (PBS ) was prep ared as
describe d by Dulb ecco and Vogt (195 4).
It was used for wash ings
of mon olay ers and as vira l dilu ent.
The com posi tion of PBS
is as follo ws:
NaCl .·. o • • • • • • •
• • • • .8.0 0 9
KCl • • •
• • • • • • • 0.20 g
Na 2 HP0 4 •
• • • • • • • • • • 1.15 g
0

0

0

KH P0
2 4 • • • • • • • • • • • • 0.20 g
CaC1
2 •• • • • • • • • • • • 0.10 g
MgC1 .6 H 0 •
• • • • • • • • 0.10 g
2
2
• •

•

0

•

•

o

0

1000 ml

PBS was ster ilize d by auto clav e.

0.5% Lact albu men -hyd rolys ate medi um (LH) was prepared acco rdin g to Fran klin et alo, (195 8).
It was used for
grow th of chic ken embr yo fibr obla sts, and cont aine
d the
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following ingredients:
90% Hanks' balanced salt solution (BSS)
10% calf serum
0.5% lactalbumen hydrolysate (enzymatic)
0.1% yeast extract

I

100 units of penicillin
50 ug of streptomycin
20 ug of fungizone

I

I

ml

ml

ml

Hanks' BSS was prepared as recommended by Hanks and
Wallace (1949).

Chicken fibroblasts were maintained for viral

titrations in a maintenance medium of 0.01% lactalbumen hydrolysate, and 5% serum.

Glutamine was added to contain 290 ug

I

mI.
Trypsin solution was prepared as given by Marcus

~

"

.al ... (1956) and consisted of the following:
NaCl • •
KCl

• •

Glucose

0

0

• • • • • • • • •

20.00 9

0

• • • • • • • • • •

1.00 9

• • • • •

2.50 9

• • • • • • • • • • •
3
Trypsin (Difco lo250)
•
•

1.45 9
1.25 9

Versene

0.55 9

• • •

0

•

0

NaHCO

0

• • • • •

Penicillin
Streptomycin

0

0

• • • • •

• • • • • • • • •

0

• • • • • • • • •

0 50 9
0

0.25 9

Deionized H 0 to 250 ml
2
This solution was sterilized'by Seitz filtration and stored at
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When needed, it was thawed and diluted 1:10 with
sterile deionized water.

Trypsinization was done in special

flasks designed for this purpose, on a magnetic stirrer.
~

£reparation and harvests of viral stock
Viral stocks were prepared in fertilized, 10-day old
chicken eggs by allantoic inoculation of 0.1 cc of 10- 3
lution of samples.

di-

Eggs incubated at 37 0 C were candled, the

air space marked, and an area selected directly above the embryo and showing no blood vessels.

The area was swabbed with

tincture of iodine, a small slit drilled through the shell
carefully, avoiding the piercing of the shell membrane.

Virus

was inoculated using a 0.5 cc syringe with a 23-gauge, 1 inch
needle, by

inse~ting

the needle through the slit, through the

chlrioallantoic membrame (CAM) and away from the embryo toward
the shell.

Eggs were sealed and incubated at 37 0 C.

The next

day the eggs were candled again, and those with dead embryos
discarded, assuming that deatffiwere due to nonspecific causes.
After 48 hours the eggs were candled again, chilled in the refrigerator, and allantoic fluid harvested.

Harvesting was

done by sterilizing the entire shell with 70% alcohol, removing the entire shell above natural air space and collecting the
fluid with a syringe, avoiding blood vessels.

The allantoic

fluids were pooled, distributed in I ml volumes in screw

i-.
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capped tubes, frozen immediately and stored at -20 o C.

The

presence of virus was determined either by hemagglutination or
by cytopathic effect (ePE)

in chick fibroblasts.

Sterility

tests for presence of bacteria were done in nutrient broth.
.

Ereparation of monolayers of chicken embryo fibroblasts
Monolayers were prepared according to Dulbecco(l952)
with small modifications.

.
,

~,

)'

."

They were needed for screening of

drug toxicities and for the titrations of viral infectivity
in the presence or absence of drugs as well as for obtaining
NDV hemagglutinin.

The following steps were employed:

','

10-12 day-old embryos were aseptically removed and placed in
sterile petri plates.

Beaks and eyes were removed, the em-

bryos cut up and these were washed with cold sterile PBS to
eliminate as muc,h blood as possible.

After washing, fragments'

",

were placed in the barrel of a 20 cc syringe and expressed into a trypsinizing flask.

Ten ml of trypsin solution was added

i

'".-

'i•.

per embryo and the contents of the flask stirred for about
20 minutes.

After trypsinization the contents of the flask

were filtered through sterile gauze, discarding undigested
connective tissue with the gauze, and the cells in trypsin distributed among several centrifuge tubes.

Cells were centri-

fuged at 600 G for 5 minutes, trypsin discarded and the pellets washed with lactalbumin hydrolysate medium.

After two

washings, cells were counted in a hemocytometer and diluted in
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LH to cont ain betw een 3-4 x 10 5 cell s /

ml and fina lly dis-

tribu ted amon g bott les or tube s and incu bate d
at 37°C .
It
was foun d that each 0.1 cc of pack ed cell s when
dilu ted with
20 ml of mediu m gave good resu lts. with mon olay
ers deve lopin g
24 hour s late r.
In spit e of hete roge nic cell orig in in thes e
prim ary cult ures . most cell s had a fibr obla stic
appe aran ce.
and th~efore they are refe rred to as prim ary
chic ken embr yo
fibr obla sts.
Thes e were not carr ied cont inuo usly . but were
prep ared as need ed.
Cylt ivati Qn of HeLa cell s
HeLa cell s were carr ied cont inuo usly .

The grow th

mediu m actu ally cont aine d 90% MEM (Eag le, 1959
), 10% calf
serum and usua l amou nts of anti biot ics.
The main tenan ce
mediu m for HeLa cell s diff ered only in the amou
nt of serum .
whic h was 4-5% . For stain ing purp oses . cell s
were dist ribu ted
5
in 1.5 ml amou nts (2 x 10 cell s / ml) . amon g smal
l Leig hton
tube s cont ainin g smal l cove r slip s.
When need ed. cove r slip s
with attac hed cell s were remo ved, cell s stain ed
by vari ous
proc edur es. moun ted on glas s slid es. and exam ined.
For RNA
extr actio ns, HeLa cell s were infe cted with NDV,
tryp siniz ed
and dist ribu ted in 3 x 10 6 cell s aliq uots amon
g tube s and fed
with main tena nce medi um. All the cell s. whet her
norm al or infecte d,

in the pres ence or abse nce of 5-flu orop heny lalan
ine,

were slow ly rota ted at 37 0 C, and afte r 24 hour
s in the incuoom~
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extr acte d for RNA.
£Uri ne boun d ribo se dete rmin ation
RNA was· extr acte d from HeLa cell s usin g the me"th
od
of Schm idt and Tanh ause r (194 5).
Puri ne boun d ribo se dete rmina tions on RNA extr acte d from HeLa cell s were
done as describe d by Mejb aum (193 9) and Cer iotti (195 5) usin
g orci nol
meth od. Read ings were done in Klett -Sum mers on
colo rime ter,
using red filte r (670 mu). For this purp ose a stan
dard ribo se
curv e was dete rmin ed, usin g the same proc edur e.
Drug s
Drug s were secu red from vari ous sour ces.

Info rma-

tion as to solu bilit ies was obta ined from Merc
k's Inde x, 7th
Ed.( 1960 ). Drug s solu ble in wate r were adde d dire
ctly to
the medi um, and ster ilize d by eith er filtr atio n
or auto clav ing
Drug s solu ble in alco hol or chlo rofo rm were diss
olve d in them
to the limi t of thei r solu bilit ies, and smal l aliq
uots adde d
to the medi um to get the desi ied conc entr atio n,
and ster ilize d
by auto clav e. Occa sion ally afte r the addi tion
of the drug s
to the medi a, adju stme nts to pH 7.3- 7.5 were nece
ssary , and
this was done with ster ile 0.3 N NaOH or 0.3N HCl.
Assa ys of drug toxi citie s
Thes e assa ys were done as desc ribed by Righ tsel
~
a!.,( 195 8). The meth od was mod ified in orde r
to obta in the
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best possible results in Leighton tubes.

Briefly it consisted

of exposing monolayers of chick fibroblasts to several concentrations of the particular drugs in maintenance LH and observing the action of the drug on the cells for a period of
several days.

Rounding of the cells, their detachment from

the glass, and the unchanged pH were criteria of toxicity.
Only the highest concentrations of drugs tolerated by cells
were used in further experiments.
Qualitative assays of viral infectivities in the presence of
QruQs.
Once the highest tolerated doses of the drugs were
determined for the chicken fibroblasts, their potential
viral activity was ascertained as follows:

anti-

Monolayers of 24-

36 hours-old fibroblasts were infected with approximately
1000 TCID

of each virus. The cells were washed with PBS
50
and the virus adsorbed for one hour at 37 0 C.
The media con-

taining the drugs were then added and the tubes reincubated.
Controls were also prepared.
cells.

Each control tube contained the

Cell control contained only LH medium, drug control

was prepared with LH medium containing the drug and the virus
control contained LH medium and virus.
ined daily for 3-5 days.

The tubes were exam-

Cytopathic effect due to the pres-

ence of virus was scored as 0,1,2,3 and 4, depending on cellular damage.

Only those drugs which inhibited cytopathic

effect to an extent of 3 (lowered CPE from 4 to 3 or lower

as

27
compared'to virus control), and in at least three out of four
tubes, were used in further experiments.
~antitative

assays of viral infectivities

These assays were performed using the method of Reed
and Muench (1938).
with cold PBS.

Infected allantoic stocks were diluted

Aliquots of 0.1 ml of each dilution were in-

oculated into monolayers of cells, using for each dilution
5-10 monolayer tubes.

The monolayers were washed with PBS,

virus adsorbed for one hour at 37 0 c with occasional tilting
of the tubes in order to spread the virus evenly.
s~rption,

After ad-

medium was added and the tubes reincubated.

Mono-

layers were examined daily, CPE scored and the viral titers
obtained.
Quantitative assays of viral infectivities in the presence of
selec ted drugs
These assays were done in exactly the same manner as
the assays described above but on the virus formed in the
chicken cells in the presence of drugso

In order to obtain

the virus, the cells in the tubes were frozen and thawed
twice and vigorously pipetted, cell debris removed by centrifugation, and the fluid containing the virus titr~ted as above
(Franklin, 1958).
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liem aggl utipa tion (HAl and hem aggl utin atioQ -inh
ibiti on (HI)
HA and HI test s (titr atio ns) were done in cupp
ed
plas tic tray s, each cup havi ng a volum e of appr
oxim ately
2.6 mI.

Chic ken bloo d for this purp ose was obta ined by
blee d
ing chic kens from the hear t and coll ecti ng the
bloo d in the
follo wing mixt ure:
sodiu m citr ate •••• •••• •••• ••• 0.8 g
sodiu m chlo ride •••• •••• •••• •• O.4 g
gluc ose •••• •••• •••• •••• •••• • 2.0 g
ster ile, dist . wate r 100 ml
Cell s were alwa ys kept in ster ile refr iger ated
Alse ver's solutio n.
When need ed for HA or HI test s, a cert ain volum
e was

remo ved, the cell s sedim ented by cent rifug atio n and
the supe rnata nt disc arde d.

The cell s were furt her wash ed in 2 chan ges

of cold PBS and' fina lly prep ared as 0.5% susp ensio
n in PBS.
The actu al HA test s were run as follo ws:

to each

cup in the plas tic tray s was adde d 0.5 ml of cold
PBS.
The
infe cted fluid s were dilu ted in PBS and to each
0.5 ml of diluted fluid 0.5 ml of 0.5% chic ken red bloo d cell
s was adde d.
cove red with a plas tic cove rand refr iger ated . Two
hour s late r
the HA tite rs were read as the high est dilu tion
of fluid
whic h com plete ly aggl utin ated the cell s.
HI test s were perfo rmed in a simi lar way.

NDV anti -

serum prev iou,s ly prep ared in rabb its was dilu ted
seIia lly twofold in 0.25 ml with PBS, and to each cup 4 HA
unit s cont aine d
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0.25 ml and 0.5 ml of 0.5% chicks RBC's were added and refrig
era"ted.

Controls were set for

HA, antiserum and RBC·s.

HI

titers were determined on the basis of the highest dilution
of antiserum completely inhibiting hemagglutination.
Antiserum
The infected allantoic fluids (stock) were prepared
in eggs as previously described.
prepared in rabbits.

Antibodies against NDV were

The NDV containing fluids were inocu-

lated intraperitoneally in 2 ml amounts every second day for
a period of 14 days.

In the third and fourth week the rabbits

received 1 ml of the infected fluids intravenously.

The rab-

bits were bled a week after receiving the final inocculation.
This immune serum was used in indirect fluorescent antibody
techniques.
Staining procedures and use of fluorescent microscopy
Some staining of HeLa cells was done with carminefast green stain (Frigan and Bird, 1963).
(Harleco-C.I. No. 46005)

Acridine-orange

staining of HeLa cells was done as

reported by Pollard and Starr (1962).

This was 0.1% solution

in McIlvaine citrate-phosphate buffer pH 3.B.

The buffer was

prepared as recommended by McIlvaine (1928).
Staining with acridine orange was done as follows:
HeLa cells on the cover slips were fixed for 5 minutes

in

","
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a glac ial acet ic acid -eth anol mixt ure.

Afte r fixa tion , cell s

were rinse d with the buff er and stain ed with 0.01%
acri dine
oran ge fbr four minu tes. They were agai n rinse
d with the
buff er and imm ediat ely moun ted in the buff er on
glas s slid es.
Indi rect fluo resc ent antib ody tech niqu es were
done
acco rding to Tamm and Whee lock (196 1). HeLa cell
s were grow n
as for acri dine oran ge stain ing. Cove r slip s
with HeLa cell s
were wash ed with PBS, fixed in acet one for 15
minu tes and
drye d.

They were agai n wash ed in PBS for 15 minu tes and
a
drop of undi luted immu ne rabb it anti- NDV serum
(HI tite rs

was

1:64 0) plac ed on the cove r slip and incu bate d
for 30 minu tes
in a hum idifi ed cham ber at 37 0 C. Afte r this ,
the cell s were
wash ed for 30 minu tes in PBS, a drop of anti -rab
bit glob ulin
serum prep ared in hors es and conj ugat ed with fluo
resc ein isothioc yana te was .. adde d and agai n incu bate d· for
30 minu tes.
Fina lly the cove r slip s were thor ough ly wash ed
in PBS for 30
minu tes and moun ted in 20% glyc erol in PBS and
exam ined. Controls were prep ared with norm al rabb it sera and
trea ted as
abov e.
Some of the cove r slip s with infe cted HeLa cell
s were
treat ed with ribo nucl ease to dete rmin e the loca
liza tion and
the synt hesi s of vira l ribo nucl eopr otein . Ther
efor e, prio r to
stain ing with fluo resc ent antib ody, infe cted cell
s were trea te(
with 0.04% solu tion of RNAse in McIl vain e pH 3.8
buff er for
1 hour at 37°C , afte r whic h time they were stain
ed and trea ted
as desc ribed abov e.

.

~
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PhotograQh~

came ra.

Pict ures were take n with Koda k Pony IV type of
For acri dine oran ge and fluore~cent antib ody phot
o-

grap hy, a 35 mm high spee d Ekta chro ne type B film
was used .
Expo sure time s were betw een 2-3 minu tes.
Carm ine-f ast gree n
prep arati ons were phot ogra phed usin g Ekta chrom
e X film .Lig ht
sour ce for fluo resc ent micr osco py was A.C. Fluo
rolum e. A
Spen cer micr osco pe equip ped with a dark field
cond ense r was
used .
The follo wing filte r com bina tions were used .
Acri dine oran ge

Fluo resc ent AB

Exci ter

Barr ier

Corn ing #511 3 (2mm)

Wrat ten #15

S-BG #12 (3mm)

Wrat ten #15

CHAPTER IV
RESULTS
Titr atio ns of vira l stoc ks
Prio r to any work , it was impo rtant to meas ure and
esta blish the infe ctio us vira l tite rs and thei r stab
ility .
For this purp ose both stoc ks were titra ted 3 time s,
usin g 10
tube s of fibr obla sts for each dilu tion . The resu lts
in
Tabl es I and Ilin dica te indi vidu al infe ctiv ity for
each titra tion and also the mean infe ctiv e tite rs with stan dard
devi ation s. Thes e dete rmin ation s were done in the span
of one
mont h; as the work prog resse d, titra tion s of both stoc
ks were
done with littl e or no chan ge in vira l tite rs.
Th~.

mean TCID
50 of NOV for chic k embr yo
fibr obla sts was 5.2 x 10- 7 and for
VSV 4.0 x 10- 6 •
DruQ tole ranc e assa ys in chic ken embr yo fibr obla sts
The resu lts of thes e expe rime nts are cont aine d in
Tabl es III and IV. It can be seen that the spec trum
of tole rated conc entr ation s rang es from 0.3~g I ml for puro
myci n to
more than 500 ~g I ml for uret hane . Drug tole ranc e
was esti mate d as desc ribed in chap ter on "Ma teria l and Meth
ods."
Thes e conc entr ation s were the maxi mal tole rate d by
the cell s,
and used in assa ys as desc ribed below .
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gyal itati ye assa ys of vira l infe ctiv ities in the Qres
ence
sU drug s
The resu lts of thes e expe rime nts are show n in Tabl es
III and IV. It can be seen that phen oxy deri vati ves
of acet ic
acid were unab le to prev ent cyto path ic effe ct (CPE)
by eith er
viru s.

Thre e indo le deri vati ves of the lowe st fatty acid s
as
well as indo le itse lf were also inef fect ive. Naph
thox yace tic
acid , naph thale neac etic acid , male ic acid hydr azid e,
gibb erel lic acid and beta -2-f uryl acry lic a~ids belo ng to the
same
categ ory in thei r inab ility to inhi bit eith er viru s.
8-az aguanin e show ed prom ise with both NDV and VSV. The othe
r two
purin e deri vati ves, name ly 8-ch loro xant hine and 6-fu
rfury laminop urin e did not inhi bit CPE. A mark ed effe ct on
CPE was
seen with dl-5 -fluo roph enyl alan ine (FPA ). Both viru
ses were
inhi bited by 30'~g of FPA I ml of medi um, and in both
case s
CPE was as low as I (Tab les III and IV).
Of the thre e antit umo r subs tanc es, puro myci n show ed
some prom ise in the inhi bitio n of NDV, mito myci n C
lowe red
CPE due to VSV and carz inop hilin was inef fect ive.
Guan idine HCI show ed inhi bito ry acti vity for the
CPE caus ed by both viru ses, altho ugh the rela ted comp
ound s of
urea and ureth ane had no effe ct.
As is evid ent (Tab les III and IV), only 5 comp ound s
were activ e in thes e test s, and thes e were 8-az agua
nine , FPA,
. PUro myci n, mito myci n C, and guan idine Hel.
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gyantitative assays of viral infectivities in the presence of
selected drugs

--

Drugs were selected for these experiments on the

basis of their ability to partially inhibit viral CPE in previouS experiments.

The procedure had to account for the time

period through which the adsorbed virus was exposed to the
action of drugs and the limitation of having available monolayers of fibroblasts in which the measurements of infectivity
were done.

One wanted to determine the extent of the viral

synthesis in the cells exposed to selected drugs, and express
this quantitatively as a function of time exposure to the
drugs.

In this manner one can obtain information on the in-

fluence of drugs on viral multiplication (Crowther and Melnick

1961).
Ten tubes with chick monolayers, were infected with
4x 10 5 virus TCID 50 • After adsorption, cells were washed
and maintenance media containing the drugs added.
Figure I shows that FPA significantly inhibited
multiplication of NOV.

Five hours after viral adsorption,

there were 280 TCID50 found in control and none in the tubes
with FPA. After 33 hours exposure to FPA the activity was
2.5 x 10 5 TCID
and 3.4 x 10 6 TCID50 in contro~. This repreSO
sents an infectivity loss of 92.7%. In other words the infectivity in FPA treated cells represented only
ity of controls.

7.3% infectiv-

In the same manner the infectivity of VSV

~~~------------~
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control after 33 hours was 1.6 x 10 5 TCID

and only 2.4 x
50
10 4 TCID50 in the presence of FPA, a loss of 85% (Figure 5).
Guanidine.HCl (Figures 2 and 6) was more inhibiting
in early hours after viral adsorptions.

The titers obtained

later were comparable to controls.
In the case of 8-azaguanine there is a slight inhibition of virus multiplication.
hibited than VSV.

NDV was somewhat more in-

VSV titers are very close to the titers of

the control, and probably not significant (Figures 3 and 7) •
. Puromycin (Figure 4) somewhat suppresses early NDV
titers, which later on approach the titers of control.
Figure 8 shows clearly that mitomycin C did not influence the
synthesis of VSV in chicken embryo fibroblasts.
As it can be seen from these experiments, the only
significant inhibition of viral multiplications was caused
by FPA.
Ihe jnfluence of FPA on viruses 1n y1tro and measurements of

their infect1yities whgn FPA addgd during different time inieryals of latent per10d e

Effect of FPA on free virus

Results of these experiments are contained in Tables
V and VI.

Control titers in these experiments are similar to

Viral titers in Tables I and II, which were obtained under
completely normal conditions.

Titers obtained in monolayers

when FPA was added at different times during latent period are

,.......,
~~----------------------------------------------------------,
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significantly lower from control
~his

titers~

The significance of

experiment will be discussed in chapter on "Discussion."

lh e influence of FPA on the formation of NDV hemagalutinin in

-chick

embryo fibroblasts
In these experiments the mono layers of chick embryo

fibroblasts were infected with usual doses of NOV.

Five HA

titrations were done in each case, reciprocal of the titers
were averaged, and expressed in percentages of hemagglutinating activity of controls.

Average titers as well as percent

of HA is.given in nearest whole numbers in Table VII.
It can be seen from Table VII that the FPA inhibits
hemagglutinin production of NOV.

Twenty pg lowered HA production to only 86% of

any effect.
controls.

Ten pg of FPA did not have

In the presence of 30pg of FPA, HA production was

only 18% of the normal controls.
The

influen_c~

of FPAon the survival of chicken embryos in-

fected with NOV and VSV
The results of these experiments are tabulated in
Tables VIII and IX.

It can be easily seen that in the sur-

Vival experiments with NDV (Table VIII) there are, after 10
days, 21 dead and6 survivors in controls, which received the
Virus but no FPA.

Experimental batch on the other hand shows

13 deaths and 13 survivors after the same period of time.
the same manner (Table IX) VSV control shows 21 dead and 4

In
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alive embryos whereas FPA treated batch has 17 deaths and 9
survivors.
The significance of .these results has been analysed
statistically, using for this purposeX 2 test (Batson, 1958)
for small numbers.
In the case of NDV. the obtained X2 for one degree
of freedom was 4.19 and p<O.05.
The X2 obtained from VSV experiments was 1.87~
giving a p>O.30.

This would mean that FPA protected or pro-

longed the survival time of chicken embryos significantly

~n

the presence of NDV but not when infected with VSV.
The studies on the inhibitory mechanism of FPA
The

effe~t

of high concentrations of FPA

OD

the synthesis of

NDV in HeLa cells
Results obtained can be seen in Jable X.
ty of control reached 2.1 x lo6TCID50.

Infectivi-

The extent of infec-

tivity in tubes.exposed to FPA inhibition for 8 hours, which
Was then released by washings and phenylalanine, was 4.3 x
lo4TCID50.

Finally, the entire 24 hour exposure to FPA yield-

ed upon titration only 302 x lo2TCID50.
The FPA inhibition was so thorough, that 24 hour FPA
inhibited samples represent 0 015% infectivity of controls.
0

Tubes.in which the FPA inhibition was released after 8 hours
still reached only 2% of infectivity in controls.
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The effe ct of FPA on RNA of norm al and NDV-inf~
cted HeLa cell s
From Tabl e XI the follo wing rela tion ship is dis-

cern ible .

If 24 hour norm al cont rol is cons idere d ~OO% then
there was incr ease d RNA synt hesi s in NDV infe cted
cell s duri ng
this perio d of time . The samp les show appr oxim
ately 11% more
of PER.

Cell s expo sed to FPA at time 0 show only 58.6% ,
a few
perc ent lowe r than norm al cell s extr acte d at time
O. Infe cted
cell s in the pres ence of FPA stil l put toge ther
some spec ific
acid inso lubl e mate rial, whic h on the basi s of
ribo se acco unts
for 67.2% of the tota l that coul d be expe cted .
Desp ite this ,
the PBR in this case is some what high er than PBR
obta ined from
norm al cell s at 0 hour . Cell s in whic h the FPA
inhi bitio n was
relea sed afte r 8 hour s, resum e RNA synt hesi s at
norm al rate .
Morp holo gical and histo chem ical stud ies
Norm al and infe cted HeLa cell s were stain ed by
Carmine -fast gree n stain (Frig an and Bird , 1963 ),
to dete rmin e
chan ges in micr osco pic appe aran ce of infe cted cell
s. Cell s
infe cted wifu NDV (Fig ures 10-1 3) show form ation
of vacu oles
and sync ytia as comp ared to norm al HeLa cell s (Fig
ure 9).
Figu re 13 show s comp lete dest ruct ion of mon olaye
r of HeLa
cell s by NDV.

Norm al and cell s infe cted with NDV were stain ed

with acri dine oran ge {Pol lard and Star r, 1962 }
to stud y any
chan ge in cont ent and dist ribu tion of nucl eic acid
s. Figu res
15-1 8 show the chan ges from oran ge to deep red
fluo resc ence ,

rr~

__________________________

~~

r"·
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indicating an increase in content of RNA due to NDV.

In the

presence of FPA this shift in fluorescence was inhibited
(Figures 19-21).

In the infected cells the syncytia and

vacuoles were also present.

In the presence of FPA the in-

fected cells did not form syncytial masses or vacuoles, but
the cells did show irregular "bumpiness" at the surface.

Fig-

ure 14 shows normal HeLa cells at time zero, and Figure 22
shows normal cells cultivated through the time period of experiments.
The HeLa cells were stained by indirect fluorescent
antibody techniques (Tamm and Wheelock, 1961) to demonstrate
the presence and location of specific viral material.
23 and 33 represent controls.

Figures

Figure 23 represents normal

cells stained with anti-NOV antibody and fluorescent tagged
""

antibody, and Figure 33 shows infected cells stained with normal serum and fluorescent antibody." In both there was no
fluorescence observed.

Figures

24~

26, 28 and 30 show

ment of specific fluorescent material.

develo~

Figures 25, 27 and 29

demonstrate inhibition of this specific fluorescent material
by FPA.

Infected cells treated with RNAse and stained with

fluorescent antibody techniques demonstrate that this fluorescent material is ribonucleoprotein (Figures31 and 32).
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TABLE"I
Titration of NDV Allantoic Stock in
Chicken Embryo Fibroblasts
Di1.

lnf.

Not inf.

% inf.

10-4

10

0

100

10-5
10- 6

10

0

100

6

4

63

10-7
10-8

1

9

7

0

10

0

"10-4

10

0

100

9

1

94

6

4

61

10-5
10- 6
10-7
10-8

2

8

13

0

10

0

10-4

10

0

100

10-5
10- 6

10

SO

4

70

10-7

3

7

21

10-8

0

10

0

Mean TCID

TCIDSciml
S.8x10 7

-6.23

-6020

6.3xl07

-6.44

3.6xl0 7

100

6

-

Neg. log.TCID

S2

=

2.58

S

=

1.60

50

=

502 x 10 7 +

1.60

r
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TABLE II
Titr atio n of VSV Alla ntoic Stoc k in
Chic ken Embr yo Fibr obla sts

% inf.

Dil.

Inf.

10-3

10

0

100

10-4

9

1

94

10-5

6

4

61

10-6

2

8

13

10-7

0

10

0

10-3

10

0

100

10-4

8

2

90

10-5

6

4

64

10-6

4

6

29

10-7

1

9

4

10-3

10

0

100

10-4

10

0

100

10-5

7

3

80

10-6

4

0
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10-7

1

9

5

Not inf.

'.

,-

S2
S

Mean TOlD

Nego log. TCID
-502 2

=
=
=

50 TCID 501m l
600 x 106

-504 0

3.9 x 10 6

-5.66

201 x 10 6

3.81
1.95
4.0 x 10 6

:t

1.95

~. -~--------------------~---------------------------.
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TABLE III
Cyto path ic Effe ct of l~'ewcastle Dise ase Viru s
in the Pres ence of Posi tive Drug s
Tole rated
CPE
Drug
Solv ent
Conc .Jlg / ml
Tube s
Beta -nap htho xyac etic acid
2
80
4 3 4 4
O-ch lorop heno xyac etic acid
1
50
4 3 4- 42,4,5 -tric hlor ophe noxy 2
40
acet ic acid
2
4 3 4 4
Indo le
2
250.
4 3 4 4
Indo l.e-3 -ace tic acid
2
220.
4 3 4 4
Indo le-3p ropio nic acid
2
200.
4
3 4 4
Indo le-3b utyr ic acid
2
200.
4 3 4 4
Napt htha lene aceti c acid
3
80.
4 3 3 4
1,2-b enza nthra cene .
3
250.
4 3 4 4
8-az agua nine
4
5,
3
2 3 3
8-ch lorox anth ine
4
10
4
3
4 4
6-furfurylamino~urine
4
20.
4 3 4 4
dl-~-fluorophenylalanine
4
30
2 1 2 2
f ormy l-dl- phen yl alan ine
460.
4 3 3 4
Chlo race tyl-d l-ph enyl 4
4
3 4 4
alan ine
4
50
Mito myci n C
4
5
4 3 3 4
Puro myci n
1
0.3
3
2 3 4
Carz 1nop hy1in
8
4
4
2
4 4
Guan idine . Hel
1
125
3
2
3
3
Urea
1
450
4
3
4 4
Azas erine
1
80.
4
3
4 4
Quer cetin
2
120.
4
3
4
4
Isati n-be ta-th iose m1
4
100
Carb azon e
4 3 4 4
Adeno-PAP-#lO.87
1
150.
4 3 4 4
No acti vity what soev er was reco rded with the follo wing
compounds
beta -2-f uryl -acr ylic acid , 100 ug; p-ch lorop heno
xyac
etic
acid ,
. 40 ug;
2,4-- dich lorop heno xyac etic acid , 40 ug; male ic acid hydr
azid e,
150 ug;
gibb erell ic acid , 150 ug; ureth ane, 500
Solv ents: 1 = wate r; 2 = 95% etha nol; 3 ug.
= chlo rofor m;
4 = 0.1% NaHC0
3
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TAB.LE IV
Cyto path ic Effe ct of Vesi cula r Stom atiti s Viru s
in the ~resence of Posi tive Drug s
Drug
2,4-di chlor ophe noxy acet ic acid
2,4,5 -tric hlor ophe noxy acet ic acid
N~phthaleneacetic acid
8-az agua nine
8-ch lorox anth ine
6-fu rfury lami nopu rine
dl-p -fluo roph enyl alan ine
Form yl-dl -phe nyla lanin e
. Acet yl-d- phen ylala nine
Chlo race tyl-d l-ph enyl alan ine
Mito myci n 0
Puro myci n
Carz inop hylin
Guan idine . HOI
Quer cetin
Isati n-be ta-th iose micarba zone

;::>olvent

Tole rated
Conc . }J.g / ml

OPE
Tube s

2

40

3 4 4 4

2
3
4
4
4
4
4
4
4

40
80
5
10
20
30
60
60

3
3
2
3
3
1

4
1
4
1
2

50
5
003
8
125
120

3
3
3
3
3
3

444
3 3 4
3 4 4
444
3 3 4
444

4

100

.,;

"%

4 4 4

4 4 4
444
3 3 3
444
444
2 2 2
'Z
.,I
444
3 444

No acti vity was reco rded with the follo wing comp ound
s:
beta -2-fu ryl-a cryl ic acid , 100 ug; beta -nap htho
xyac
etic
acid ,80;
O-ch lorop heno xyac etic acid , 50; p-ch lorop heno xyac etic
acid
,40j
Indo le, 250 ug; indo le-3 -ace tic acid , 220 ug; indo le-3prop
ionic
acid , 200 ug; indo le-3 -but yric acid , 200 ugj male ic acid
hydr
a-.
zide , 150 ug; gibb erel lic acid , 150 ug; 1, 2-be nzan thrac
ene
,
250 ug; urea , 450 ug; ureth ane, 500 ug; azas erin e, 80
ug;
adeno -PAP #108 7, 150 ug.
Solv ents: 1 = wate r, 2 = 95% etha nol, 3 = chlo rofor m,
4 = 0.1% NaH00 •
3
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TABLE V
The Influ ence of FPA on NDV Tite r When Added Duri ng
Diff eren t Inte rval s of Late nt Peri od.
NDV Expo sed to .bIPA* in Vitro
for Six Hour s
0.01% LH - FPA Medium Hour s
Afte r Adso rptio n

o
1
2

3
cont rol (no FPA)

*JfPA cone . 30 pg/m l

2.4 x 10 6
108 x 10 6

3.2 x 10 6
4.1 x 10 6
4.4 ;. 107

r

I

-
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TABLE VI
The Influ ence of FPA on VSV Tite r When Added Duri ng
Diff eren t Inte rval s of Late nt Peri od.
VSV Expo sed to FPA* in Vitro
for Six Hour s
0001% LH - FPA Medium Hour s
Afte r Adso rptio n

o
1
2

3

cont rol (no FPA)

*FPA conc . 30 pg/m l

TCID

50

1.8 x 10 5
3.4 x 10 5
3.6 x 105
7.1 x 10 5
3.2 x 10 6

.
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TABl.E VII
The Influence of

.lfPA

on the Formation

.'

of NDV Hemagglutinin in Chick
Embryo Fibroblasts

pg

m.l Medium

FPA /

HA Titer

% HA

o

22

100

10

22

100

20

19

86

30

4

18

.'
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TABLE VIII
The Effe ct of FPA on the Mor talit y of Chic ken
Embryos Infe cted with NDV. Cont rol Group
Rece ived 100 TCID
50 of Viru s/Eg g.
Expe rime ntal Group Rece ived Viru s
in the Pres ence of 75 Pg of
EPA/Egg. Both Grou ps
Inoc ulate d Alla ntoi cally and Expe rime nt
~L'erminated at Hatc hing Time .
Embryos
Aliv e

Dead

NDV

6

21

NDV
FPA

13

13

26

Tota l

19

34

53

2

X (c)l

= 4.19

p <:::.

Tota l
'C.7

0.05
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TABLE IX
The Effe ct of FPA on the Mor talit y of Chic ken
Embryos Infe cted with VSV. Cont rol Grou p
Rece ived 100 TCID
of Viru s/Eg g.
50
Expe rime ntal Group Rece ived Viru s
in the Pres ence of 75 Pg of
lJ'PA/Egg. Both Grou ps
Inoc ulate d Alla ntoi cally and Expe rime nt
Termin~ted at Hatc hing Time .
Embryos
Aliv e

Dead

VSV

4

21

25

VSV
FPA

9

17

26

13

38

51

Tota l

Tota l

2

X (c)l = 1.87

P':>

0.30
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0.015

50

TABLE XI
Puri ne Bound Ribo se (PB~)Estimations on RNA Extr acte d
from HeLa* Cell s UnQer Vari ous Trea tmen ts.
FPA Conc . 300 J1g / Ml of MEM
Trea tmen t

% Cont rol at 24

Normal cell s - 0 hour

18.8

62.2

Normal cell s - 24 hour s

30.2

100. 0

NDV infe cted cells - 24 hour s
Cell s - FEA - 24 hour s

3305

110. 9

1707

5806

20.3

6702

26.0

8600

Cell s - NDV - FPA - 24 hour s
Cell s - NDV - FPA - 8 hour s

*

}Jg PHR

3 x 10 6 cell s per tube

h
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CHAPTER V
. DISCUSSION
Of the three

gen~ral

methods available for the study

of viral chemotherapy,. the tissue cuI ture method and the
bryonated egg method were chosen.

em~

The tissue culture method

is preferable in spite of some criticism that it does not indicate whether an antiviral drug will be active in an infected
animal.

This same criticism has been raised in the case of

in vitro antibacterial antibiotics tests.

It is understand-

able that an in vitro test (Hermann, 1962) can not reflect all
the in vivo factors acting on adsorption, excretion, toxicity
and detoxification of the test drug.

All the drugs, therefore

which exhibit ~tgh activity in vitro and low or no activity in
vivo, should be returned to the laboratory for the modification of the molecule and further investigation.
The final and crucial tests on the selected antiviral agents in vitro, should be done in laboratory animals.
Tissue culture methods used in this work were of
two types.

The method of Herrmann et al., (1960) employs

agar-diffusion for the detection and bioassay of antiviral
drugs.

The method was tried at the start of this work and

was modified several times.

The results obtained were incon-

sistent and therefore it had to be abandoned.

Parallel with
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this, a liquid type of tissue culture method was used (Rightsell et al., 1958) which was modified according to our needs.
It consisted of preparation of monolayers (Dulbecco, 1952) of
chick embryo fibroblasts in which the various drugs in solutio
were then assayed for aritiviral activity.
good and reproducible results.

This method gave

In order to use a liquid type

of tissue cultur~ in chemotherapeutic work, two important requirements had to be considered here.

The proper solvents

must be selected for the drugs to be tested so that they can
be removed from the media once the drugs are dissolved.
The second problem was the variation of the pH of
the media due to the presence of the test drug.

Mammalian and

avian cells exhibit normal activities of metabolism and growth
in a narrow range of hydrogen ion concentration.

The physio-

'.

logical pH for these' cells is between 7.2 - 7.6 and it is important that the starting cultures of such cells be within
this pH range.

The pH of the medium containing the variety of

the drugs was adjusted and buffered for this range.
Assays of drug tolerance of chick embryo fibroblasts
were done prior to work with viruses.

Viral synthesis inside

a susceptible host cell is intimately associated with cellular
enzymatic processes.

It is, therefore, necessary to deal with

the highest possible concentrations of the drugs tolerated by
the cells in order to expect chemotherapeutic action based on
selective toxicity.

The therapeutic concentrations in many
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instances approach toxic levels, and it is in such situations
very difficult to dissociate therapeutic effect of a drug from
its toxicity.
Toxic concentrations induce changes in the cells
which are difficult

Or

impossible to distinguish from the

effects due to the virus.
The effects of viral multiplication in tissue cultures may be detected in a number of ways.

Degenerative

changes in the cells or pH changes take place as the result of
decreased metabolism.

One can also harvest viral fluids and

inoculate serial dilutions into animals or developing chicken
embryos and calculate the 50% infective, lethal or paralytic
doses.

One can also estimate hemagglutinin (HA) or comple-

ment fixing (CF) titers from fluids.

In this work the cri-

teria of viral presence was cytopathic effect (CPE), hemagglutinin production and histochemical changes.

Huang (1942),

and others recognized, that the mUltiplication of viruses or
their presence in tissue cultures brings about degenerative
ch?nges, which provide adequate proof of their presence. These
changes are generally described as cytopathic effect.

Dif-

ferent viruses affect different cells in a variety of ways.
The cytopathic effect comprises all the changes in virus infected cells which make them appear granular, rounded up, accumulated in irregular masses without a clear distinction as
to individual cells, and finally degeneration and complete
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disintegration.

These changes had to be specifically induced

by viruses in order to decide any therapeutic potential of
drugs.
Qualitative assays of infectivity in the presence
of the drugs were performed to select the drugs with potential
antiviral activities.

Even the partial inhibition of CPE in

such tests is adequate reason to consider any inhibitive drug
as a potential therapeutic.

From Tables III and IV it can be

seen that only five drugs passed the criteria as formulated
in the chapter on "Materials and Methods.".

These drugs were

mitomycin C, guanidine Hel, 5-fluorophenylalanine, 8-azaguanine and puromycin.
But the lowering of CPE per se might not always mean
reduction in infectious titer or suppression of viral multiplication.

Groupe, et alo,

(1952, 1954) have shown this in

vivo with xerosine.
This possibility was investigated in vitro with
drugs in qualitative assays by measuring the infectivities
after different time intervals of exposure to the drugs.

The

lowering of the CPE in such situations with no inhibition of
viral multiplication could still be considered therapeutically
effective.

Whatever the meaning of inhibited CPE in such

situations might be, when projected in vivo it can mean two
things: Either disappearance of the symptoms or the drug is
provoking tissue reactions which are manifested by a decrease
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in cellular destruction.

In some human diseases, for example

influenza, the disappearance of the symptoms in spite of extensive viral multiplication could be regarded as beneficial,
(Herrmann, 1962).
From the results (Figures 1-8) of quantitative
assays of viral infectivities in the presence of drugs which
previously inhibited CPE, only FPA inhibited the multiplication 'of viruses significantly.
The inability of mitomycin C to inhibit multiplication of VSV (Figure 8) can be explained on the basis of observations of several groups (Reich and Granklin, 1961; Shatkin
et al., 1962; Ben Porat, et al., 1961).

Mitomycin C apparent-

ly acts only on DNA of the cell and the virus, and since VSV
is an RNA containing virus (Hossein and Cooper, 1963), mitomycin C does not affect its multiplication.

Puromycin did not

suppress the multiplication of NDV (Figure 4) at concentration
tolerated by cells.

Higher concentrations of puromycin

(5 ug / ml) Levintow, et al.,

(1962) inhibit poliomyelitis

virus in HeLa cells, but this concentration is extremely toxic
for the cells.
Guanidine.Hel (Figures 2 and 6) influences the multiplication of NDV and VSV only early after adsorption. Later,
the final titers of both viruses approached the titers of controls.

Melnick, et al.,

(1961) reported that low doses of

guanidine. HCl, at least with enteroviruses, select viral
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particles with varying degrees of resistance to the drug. This
mechanism might explain the early lower titers in our case.
Guanidine.HCl inactivated a certain proportion of initial infective dose of each virus giving less infectivity in fhe beginning, which picked up later and reached the control titers.
8-azaguanine was ineffective with VSV.

The titers

(Figure 7) were very close to the titers of control.

In the

case of NDV (Figure 3) 8-azaguanine shows small but definite
inhibition.

Despite this the viral titers are wthin one

standard deviation of controls.

It would be interesting to

work with some other guanine derivatives.
The only drug showing significant inhibition of multiplication of both viruses was FPA.

FPA (Figure 1) lowers

the final NDV t.iters to approximately 7% of control.

At 5

hours after adsorption, titer of the control was on the average 2.8 x 10 2 TCID
whereas titer of FPA inhibited test was
50
below 10 2 TCID
and therefore not measurable using tenfold
50
dilutions.
Similar results were obtained with VSV (Figure 5)0
The differences between both viruses is in their infectivity
for chicken embryo fibroblasts.

Titration of NDV stocks in

chick fibroblasts always gave higher titers than the stocks
of VSV.

The reason for this probably lies in the nature of

host-virus system.

Chicken cells provide a natural host for

NDV which is not the case with VSV, which is a
gen of horses and cattle.

natur~l

patho-
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The lower titers (Franklin, 1958) of both viruses in
these tests as compared with the titers achieved in direct
titrations of allantoic stocks are without doubt due to some
viral inactivation during freezing and thawing of the cells.
Despite this fact, the relative inhibition of viral multiplication in the presence of' the drug is still evident from these
experiments.
Rubin et al., (1957) showed that 95% of cell associated NOV can be neutralized by immune serum.

Since it is

known that the antibody molecule does not enter the living
cell, thisneutralizable but cell associated virus (CAV) must
be somehow exposed to the action of antibody.

NOV is asserrbled

in the cytoplasmic membrane and remains, after maturation,
connected

with~e'

outer cellular surfaces for approximately

one hour, after which it is finally released into the medium.
Because of this, there existed a possibility that FPA might
be acting extracellularly, namely either on the virus still
associated with cell or on free virus in the medium.

In order

to be sure that FPA does not act as a virucidal agent on the
viruses used in this work, experiments were performed to test
this possibility.

FPA had no effect on the free virus as seen

from control titers (Tables V and VI).

Nor did FPA exhibit

any detrimental effect during the adsorption period.
Ellis and Delbruck (1939) with bacterial viruses and
Dulbecco and Vogt (1954) with animal viruses demonstrated that
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after penetration of viral nucleic acid into a susceptible
cell, a period follows during which the infectivity cannotbe measured or recovered, and any remaining measurable infectivity is due to free and unadsorbed virus.

Also during this

period of time no virus specific material of any kind can be
detected within such cells.

After this period, which in dif-

ferent systems may take a few minutes, several hours or even
days, viral specific materials start to appear, but measurable
infectivity, if any, is still due to residual free virus. This
time period is called the eclipse phase, and together with the
maturation phase,

(time interval in which first viral material

starts to appear and up to the time when the first increase in
infectivity is detected) comprises the "latent period" of viral
development.
The latent period of NDV in chick embryo fibroblasts
is approximately 3 hours (Levine and Sagik, 1956), of which 2
hours (Tamm and Wheelock, 1961) are taken by eclipse.

The VSV

latent period in the same host is between 2.5-3 hours, of
which 1.5-2 hours belongs to the eclipse (Franklin, 1958). An
infected cell culture (low multiplicities) exhibits continuously all phases of viral development; new cells are infected
during release of finished virus products; in some of the
cells virus is eclipsed, in the others in the process of
ation and so on. (Tables V and VI).

matu~

The suppression of viral

infective titers was evident when FPA was present during
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different time intervals of the latent period as well as
throughout the extended periods, indicating the intracellular action of FPA (Tables V and VI).
When FPA is present in a glycerol-salt medium during the adaptation of Ee coli to lactose fermentation, the
growth rate of the organism becomes linear rather than exponential (Munier and Cohen, 1959).

Such a possibility is

discernible from the experiments with NDV hemagglutinin
(Table VII).

There is, of course, no analogy between EeColi

and its galactosidase on one side

a~d

the synthesis of viral

hemagglutinin by mammalian or avian cellon the other.

The

similarity is the ability of both to synthesize enzyme proteins.

If FPA renders a bacterial enzyme

nonf~nctional

by

virtue of its incorporation into the enzyme molecule, there i
a good possibility that a similar sequence of events will occur in virus infected cell in the presence of FPA.Zimmerman
and Schafer (1960) showed in the case of fowl pl~gue virus
that the presence of FPA during the eclipse phase inhibits th
synthesis of viral protein.

Later addition of FPA allows the

formation of S antigen but not of viral hemagglutinin. The S
antigen of myxoviruses is believed to be a nucleoprotein,
which forms before the capsid protein containing HA activity.
In our experience, 30 ug of FPA lowered the HA activity of virus to about 18% of the titer of control.

Does

FPA cause synthesis of less infectious virus or of nO'1furcticoal
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HA?

If there is less virus formed there is also less hemag-

glutinin formed.

On the other hand the viral nucleic aeid

could be infective but HA is not functional.
In order to determine the effect of FPA on viruses
under more realistic conditions, namely iri a living host that
is easily infected and killed by the virus we used embryonated
chicken eggs.

Embryos are suitable for this

there are some disadvantages involved.

purpose~

although

The factors which had

to be considered were as follows: toxicity of FPA, dose of the
virus which had to be large enough to infect and kill, but
also small enough so that it could be acted upon by relatively .nontoxic doses of FPA.
In the case of NDV, 75jUg of FPA protected or prolonged the time of survival of infected embryos significantly.
This conclusion is based on the outcome of statistical analysis of the results.

However, embryos were not protected

against VSV as revealed from chi square tests.

This differ-

ence could be due to the nature of the virus and the response
of embryo host.

VSV, although "adapted," is not a natural

pathogen for chickens.

If epidemiological theory is correct,

such a relationship is much harder for host than an infection
with natural pathogen.
The

e~periments

which were undertaken to study the

mechanism of FPA inhibition were of three kinds.
Again the infectivity of virus synthesised during
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exposure to a large concentration of FPA had to be measured
and compared to noninhibited controls as well as to the infectivity obtained from FPA inhibited cultures in which the
inhibition was later released by removal of FPA containing
medium and introducing medium rich in phenylalanine (PA).
Secondly, an important component of the cells had to be obtained and measured under variety of treatments, a component
which could be, during internal virus development, shared
with the virus or at least have a biological function similar
to one of the viral

components~

And thirdly, the individual

results obtained in the.rJISttwo steps as well as the conclusions
extracted should be then analysed in connection with the results obtained from histochemical experiments.

In order to

insure as much··uniformity as possible, a homogenous cell culture had to be used in these experiments.

HeLa cells are

preferable over primary chicken fibroblasts.

A homogeneous

cell line was preferred in histochemical studies because of
morphological considerations as well as for analytical reasons
inc biochemi cal experiments.
Addition of FPA during early eclipse period and its
presence during a24hour period completely suppresses the formation of infectious viral particles (Table X).

Any infectiv-

ity recorded was probably due to some residual unadsorbed
virus.

The hemagglutinin activity was zero, indicating that

there was no synthesis of protein or at least functional
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hemagglutinin.

Infected cells exposed to FPA for 8 hours and

in which the inhibition was then reversed, showed a significant

in~rease

in infectivity over 24 hours inhibited samples.

But the HA activity of this .sample was the same as in the
sample inhibited for 24 hours.

There was actually a 134 fold

increase in the infectivity over the 24 hour sample, whereas
HA activity remained the same.

Only in the control sample

which was not exposed to FPA, HA activity was recorded at
4

HA units.

The possibility that FPA inhibits hemagglutinat-

ing activity in vitro was tested with the virus from controls.
This was not the case, since dilutions were made in medium
containing FPA, and the hemagglutinating activity remained
steady at

~

HA units. From these experiments we conclude that

FPA inhibits

~?th

cellularly.

Reversal of FPA inhibition results in the in-

infectivity and HA production acting intra-

crease of infectious titer, .but there is still not enough
virus to give ,concentrations of enzyme necessary to agglutinate red blood cells o
Since NDV is an RNA containing virus and since vira
infection implies the synthesis of viral

&~A,

we wanted to

study the influence of FPA on the RNA synthesis of normal
cells, and virus infected cells in order to obtain further
information on the mechanism of FPA inhibition.
This was done by the determination of ribose content in RNA extracted from HeLa cells which underwent

diff~nt
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treatments.

If the purine-bound ribose from tubes of 24

hours growth of normal HeLa cells represents 100% (Table XI),
then there is a net increase of approximately 11% of ribose
in-the cells infected with NOV despite their progressive destruction.

This indicates either viral RNA synthesis, or at

least increase in acid insoluble material whLch is well on its
way to incorporation either in cellular or viral RNA.

On the

dher hand, purine bound ribose from infected cells in the
presence of FPA was only 67.2% of ribose
24 hour controls.

re~orded

in normal

Compared with normal cells which were cul-

tivated through the same time period in the presence of FPA,
these infected FPA inhibited cells still show some increase
(8.6%) over the PBR value obtained in noninfected FPA inhibited control.

This would mean complete inhibition of RNA syn-

thesis in normal cells treated with FPA, but some synthesis
in-infected FPA treated cells.

These PBR values are compared

to normal controls at 0 time, which in the terms of 24 hours
normal control represents only 62.2% of the net amount.
Finally the infected and 8 hour FPA treated cells in which
,

the inhibition was counteracted by washings and phenylalanine
gave a PBR value of 26.0 ug which is much higher than the
value obtained with infected - FPA treated cells for 24 hours,
but still smaller (86%) than value obtained from infected and
untreated cells.

This indicates that the RNA synthesis in

this case continued after

re~se

of FPA inhibition.
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Histochemical studies done on HeLa cells in connection

w~th

above work corroborate these findings, and in

some instances expand these results.

Acridine orange studies

clearly reveal the changes in the infected cells that are due
to the viral infection.

The gradual accumulation of viral

RNA (Figures 14-18) in the infected cells is shown by the
shift in color (Armstrong, 1956; Schummelfelder, et al., 1957)
from reddish-orange to dark flame red.

Infected, but FPA

treated cells do not undergo this shift, or at least this is
. not very pronounced (Figures 19-21).

This agrees with the

experiments on purine bound ribose obtained from infected-FPA
treated cells.

In spite of this fact,

there appears, on the

basis of PBR experiments (Table XI) the possibility of some
viral RNA synth,esis in such cells.

Acridine orange is not

sensitive enough to detect this change.

Fluorescent antibody

techniques (Figures 23-30) reveal the formation of vi~al
specific material in the cells despite the presence of FPA,
which from previous experiments, definitely inhibits the production of infective viral particles and hemagglutinin. Viral
material is synthesised in such cells although to a lesser extent.

In the FPA inhibited cells exhibiting specific viral

fluorescence, virus material could be nucleoprotein or S Antigen.

Treatment of such cells with ribonuclease (RNAse) for

one hour at 37 C removes this fluorescent material (Figures
31 and 32)0

This material could not be viral nucleic acid
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alone, because nucleic acids are not antigenic, and therefore,
cannot

be responsible for the induction of antibody forma-

tion.
It is therefore possible that ribonucleic acid in
this case is hapten t

which is broken down to oligonucleotides

and smaller units through the action of RNAse.

Immunologic

specificity is lost, and as a consequence, fluorescence also.
The question that arises here is as follows: if high
concentrations of FPA inhibit RNA synthesis, a conclusion
drawn from previous experiments, how is it possible that viral
RNA or viral ribonucleoprotein appears in such cells?t

It

seems that the assumption of Scholtissek and Root (1961), derived from work on fowl plague virus t
of NDV t

is pertinent in the case

namely.thata protein (polymerase), once formed in the

early eclipse phase, directs the synthesis of some viral RNA
or ribonucleoprotein.

This might go on even during the time

tha t FPA inhibits the forma tion of viral hema gglutinin and
viral maturation.

In such case, viral protein and nucleo-

prptein formed contains instead of phenylalanine the analog
FPA.

This material is immunologically active as shown with

fluorescent antibody techniques, but inactive concerning its
neuraminidase activity as well as its infectivity.

SUMMARY
Chemotherapeutic experiments involving 30 different
drugs and two animal viruses yielded 2 drugs which have the
ability to suppress the infectivity of Newcastle disease virus and vesicular stomatitis virus in tissue cultures.
Of the two drugs, 5-fluorophenylalanine, an analog
of amino acid phenylalanine, exhibited significant inhibition
of infectivity of vesicular stomatitis virus and Newcastle
disease virus as well as the inhibition of the formation of
Newcastle disease virus hemagglutinin.
The other selected drug, 8-azaguanine, an analog of
guanine, had more effect on the infectivity of Newcastle disease virus, although not as significantly as 5-fluorophenylalanine.
In the experiments with fertilized chicken eggs, it
has been shown that 5-fluorophenylalanine definitely prolongs
the survival time of chicken embryos infected with Newcastle
disease virus, which on the other hand cannot be claimed in
the case of embryos infected with vesicular stomatitis virusol
The studies on the mechanism of action of 5-fluoro.phenylalanine were done in HeLa cells and only with Newcastle.
disease virus.

For this purpose 10 times higher concentra-

tions of 5-fluorophenylalanine (300~g

Iml) were used than i

1
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previous experiments, since the criterion of selectivity was
not important in these studies.
The biochemical studies revealed that 5-fluorophenyla.lanine inhibits general cellular RNA synthesis which would
also mean inhibition of protein synthesis, which then reflects
itself in the suppression of viral infective titers as well
as in the production of enzyme neuraminidase responsible for
hemagglutination.
Upon release of 5-fluorophenylalanine inhibition,
~y washing the cells and introducing into mediuffi normal amino

.cid phenylalanine, the inhibition of viral infectivity stops,

i.e., more infective virus is formed.

From these experiments

it is concluded that 5-fluorophenylalanine inhibits not only
~he RNA and protein synthesis,
'.

but also the maturation of

ully infectious viral particles.
Histochemical studies, using acridine orange and

~luorescent antibody techniques, confirm the above findings.
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ABSTRACT
Title:

Chemotherapeutic Experiments With Ribonucleic
ACid Containing Animal Viruses.

Purpose:

The purpose of this work was to select drug(s)

which exhibit selective toxicity for 2 RNA containing animal viruses, Newcastle disease virus
(NDV} and vesicular stomatitis virus (VSV) when
grown in primary cultures of chicken embryo
fibroblasts,· and using biological, biochemical
and histochemical techniques, to study the
mechanism of action.
Introduction: .. Chemotherapy of viral diseases is a difficult
undertaking.

The problem is not so much due

to the unavailability of drugs, their solubilities and active or passive transport into virus
infected cells as it is due to the intricate
relationship of the host-parasite system itself,
Upon infection of a cell, viral nucleic acid,
which is the carrier of genetic code for the
synthesis of its own protein and nucleic acid
subunits, reorients the aspect of cellular
metabolism in the direction which provides all

necessary enzymes, building blocks and energy
for the formation of new viral material.

The

formation of viral subunits and theirsubsequent assembly into mature and fully infectious virus is integrated with remaining cellular processes, so that it is difficult to
achieve, by use of drugs, a significant toxicity for the virus without disturbing normal
cellular metabolism.

Usually, a certain drug

concentration which is toxic for virus or inhibitive for certain anabolic function{s)

lead-

ing to the formation of virus is simultaneously toxic for other cellular processes.

It is

the intimate parasitic relationship at the enzymatic and molecular level in viral diseases
which makes it difficult to efficiently separate the antiviral action of drugs from their
general toxicity for the infected hosts.
In spite of this, certain drugs show selective
toxicity for certain viruses, although almost
entirely in vitro.

Most of these studies on

the chemotherapy of viral diseases had not as
yet contributed to any significant practical
use, although they were responsible for many
interesting findings of the parasitism at the
cellular and subcellular levels which

I

~

contributed to the general knowledge of viruscell relationship.
Results:

It was logical, therefore, to assay or estimate
in the beginning experiments the highest tolerated doses of various drugs in the cellular
system in which most subsequent studies were to
be performed.

Only at such concentrations can

one reasonably expect to achieve selective action.

For this purpose, chicken embryo fibro-

blasts were used and the assays were done using
30 drugs in liquid tissue culture systems.

Af-

ter ascertaining the highest tolerated doses of
the drugs by chick embryo cells, the next step
was to measure; qualitatively, the ability of
these drug concentrations to suppress viral cytopathic effect (CPE) in chick cells.

In both

instances, 1000 TCID

of virus were used to
50
infect cell monolayers, which were then incu-

bated in the presence of medium containing the
drugs, and observed for 3 to 5 days for the
development of CPE, which was then scored as
0, 1, 2, 3 and 4 when compared to controls.

ThE

drugs showing inhibition of CPE under these conditions were used in quantitative assays, to
estimate specific loss of infectivity expressed
in TCID 50 when compared to controls, as well as

~

to analyze the significance of this inhibition.
On the basis of CPE inhibition in qualitative
tests, 5 drugs were selected for quantitative
studies.

The drugs were 5-fluorophenylalanine,

8-azaguanine, guanidine.Hel, mitomycin, and
puromycin.
Quantitative assays were performed by infecting
chicken embryo monolayers with 4 x 10 5 TCID
50
of virus, and after adsorption, media were added
containing the above drugs in highest tolerated
concentrations.

At 5, 10, 23, 28 and 33 hours

after viral adsorption, the infected monolayers
were frozen and thawed twice, cell debris sedimented by centrifugation, and supernatants

ti-

trated in chick cells grown in normal medium;
titrations were done using Reed and Muench
method.

From the results of these studies it

could be seen that 5-fluorophenylalanine (FPA)
significantly inhibits infectivity of both viruses in chicken fibroblasts.

NDV infected

cells treated for 33 hours with 30 ug of FPA/ml
of medium showed only 7.3% infectivity of controls, whereas in the case of VSV the FPA
treated cells showed 15% infectivity recorded
in controls.

t

Of the rest of the drugs only 8-azaguanine
showed some inhibition of NDV, which on the
basis of statistical approach was notsignificant.
The addition of FPA containing medium to chick
embryo monolayers during different times of
latent periods of both viruses significantly
lowered both infective titers, confirming above
findings, whereas exposure of viruses in vitro
to FPA did not have any effect on final titers
in chick cells.
It has been shown in the case of NDV that FPA
significantly lowers its hemagglutinin titer.
In the presence of 30 ug of FPA the NDV hemagglutinin activity was recorded and represented
only 18% of HA activity of controls.

Since FPA

suppresses viral infectivities and in the case
of NDV also the hemagglutinating activity, it
is reasonable to assume that this is due to FPA
incorporation into viral subunits rendering
them nonfunctional.

The experiments with FPA

in embryonated eggs showed on the basis of statistical analysis that 75 ug of FPA significantly prolongs the survival time of embryos in the
case of NDV infections.

VSV infected embryos

on the other hand did not respond significantly
to the treatment with FPA, and the reason for
this could be sought in the epidemiological hypotheses.
The studies on the actual mechanism of FPA inhibition were performed with only NDV.

For

this purpose homogeneous cell cultures (HeLa)
were used in order to obtain more uniform results.

It is shown that 300 ug of FPA per ml

of Eagles MEM maintenance medium completely inhibits the formation of infectious NDV; this
inhibition could be released as shown in the
experiment with 8 hours FPA inhibited and NDV
infected cultures.

After thorough washing of

such cultures with PBS and addition of MEM rich
in phenylalanine synthesis of fully infectious
virus takes place as revealed by increased
viral titers.

It has been further shown in the

purine bound ribose experiments that FPA generally inhibits cellular RNA synthesis and that
in spite of this fact some RNA is synthesized
in virus infected cells. That this RNA could be
of viral origin has been shown using histochemical techniques, especially fluorescent antibody procedures. On the basis of these experiments the following conclusions can be drawn:

FPA inhibits yiral infectivity and hemagglutinin, and general cellular RNA synthesis.

Spe-

cific fluorescent material observed in the infected and EPA treated cells is viral nucleoprotein which is nonfunctional due to the presence of FPA moieties.

Relea~e

of FPA inhibitior

results in the synthesis of normal virus, meaning that FPA might inhibit also viral maturation.
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